Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This patient did not experience any complications during surgery or after the surgery, however, the patient was required to wait over 10 months for the surgery and it cost nearly USD 1 million [75].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [75]
Citations
Cites
Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration
Mandai, M., Watanabe, A., Kurimoto, Y., Hirami, Y., Morinaga, C., Daimon, T., Fujihara, M., Akimaru, H., Sakai, N., Shibata, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608368 · Cited by 1,509
Palejwala, N. V., Jia, Y., Gao, S. S., Liu, L., Flaxel, C. J., Hwang, T. S., Lauer, A. K., Wilson, D. J., Huang, D., & Bailey, S. T. (2015) · Retina · doi:10.1097/iae.0000000000000867 · Cited by 165
Chau, M. J., Deveau, T. C., Song, M., Gu, X., Chen, D., & Wei, L. (2014) · Stem Cells · doi:10.1002/stem.1802 · Cited by 91
Research works printed but not linked: 1
- Seaton AD, 1992, Invest Ophthalmol Vis Sci, 33, 83
Cited by
Items 101–171 of 171
Prospective applications of induced pluripotent stem cells in military medicine
Saha, B., Kumar, H. K., Borgohain, M. P., & Thummer, R. P. (2018) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2018.03.005 · Cited by 9
“A sheet of patient-specific RPE cells were successfully derived from episome-generated iPSCs and transplanted onto their donors without any adverse after-effects.(19) The ability to generate such a large variety of crucial cell types provides a great impetus to regenerative therapy for even themost severe ocular injur…”
BackgroundRongying, Z., Mao, Y., Xiong, L., & Li, L. (2018) · Current Genomics · doi:10.2174/1389202919666181012145416 · Cited by 7
AMD and Stem Cell-Based Therapies
Giacalone, J. C., Parkinson, D. H., Balikov, D. A., & Rao, R. C. (2023) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000510 · Cited by 7
“86 iPSCs were derived from skin fi broblasts and were differentiated into RPE cells.”
MethodKitahata, S., Mandai, M., Ichikawa, H., Tanaka, Y., Senba, T., Kajita, K., Sugita, S., Kadonosono, K., & Takahashi, M. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2023.12.016 · Cited by 8
“Over the past decade, utilization of RPE derived from embryonic stem cells (ESC) or induced pluripotent stem cells (iPSC) has attracted signi fi cant attention as a promising cell-based regenerative therapy for such retinal degenerative conditions [3] [ e ] [6].”
BackgroundOcular stem cells: a narrative review of current clinical trials
Sotiropulos, K., Almaliotis, D. D., Ploumidou, K., & Karampatakis, V. E. (2022) · International Journal of Ophthalmology · doi:10.18240/ijo.2022.09.17 · Cited by 7
Induced Pluripotent Stem Cells for Clinical Use
Vanneaux, V. (2019) · Update on Mesenchymal and Induced Pluripotent Stem Cells · doi:10.5772/intechopen.88878
Wang, M., Idei, H., Wang, C., Liang, Y., Liu, Y., Matsuda, Y., Takahashi, K., Kamioka, H., & Naruse, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-16063-9 · Cited by 6
Ex Vivo Production of Platelets From iPSCs: The iPLAT1 Study and Beyond
Sugimoto, N., & Eto, K. (2023) · HemaSphere · doi:10.1097/hs9.0000000000000884 · Cited by 6
Hwang, J. C., Staropoli, P. C., Kuriyan, A. E., Yannuzzi, N. A., & Sridhar, J. S. (2020) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000329 · Cited by 5
Shan, W., Zhou, L., Liu, L., Lin, D., & Yu, Q. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10051 · Cited by 5
“Recently, trials on ESCs or iPSCs derived from neural cells have been assessed as a treatment for Parkinson's disease and macular degeneration (9,10).”
BackgroundUpdate on Mesenchymal and Induced Pluripotent Stem Cells
Al‐Anazi, K. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.77857 · Cited by 5
Hayashi, Y., Ohnishi, H., Kitano, M., Kishimoto, Y., Takezawa, T., Okuyama, H., Yoshimatsu, M., Kuwata, F., Tada, T., Mizuno, K., et al. (2023) · Tissue Engineering Part A · doi:10.1089/ten.tea.2023.0214 · Cited by 4
Cautious Optimism Warranted for Stem Cell-Derived Islet Transplantation in Type 2 Diabetes
Scholz, H., Sordi, V., & Piemonti, L. (2024) · Transplant International · doi:10.3389/ti.2024.13358 · Cited by 4
SOX2 for Stem Cell Therapy and Medical Use: Pros or Cons?
Chuang, H.-M., Huang, M.-H., Chen, Y.-S., & Harn, H. (2020) · Cell Transplantation · doi:10.1177/0963689720907565 · Cited by 4
Animal Models and Experimental Research in Medicine
Karapehlivan, M., Gelen, V., & Kükürt, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100993 · Cited by 5
Jamal, M., Bashir, A., Al‐Sayegh, M., & Huang, G. T. ‐. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822135-8.00007-0 · Cited by 5
Pollalis, D., Georgescu, C., Wren, J. D., Tombulyan, G., Leung, J., Lo, P.-A., Bloemhof, C. M., Lee, R. H., Bae, E., Bailey, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.09.588773 · Cited by 4
Induced pluripotent stem cell technology: venturing into the second decade
Shi, Y., Inoue, H., Takahashi, J. B., & Yamanaka, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00095-2 · Cited by 5
Large Animal Models in Cardiovascular Research
Osada, H., Murata, K., & Masumoto, H. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.105754 · Cited by 3
Urine-derived stem cells ameliorates the aging of retinal pigment epithelial cells
Shi, L., Li, N., Zhang, M., Liu, J., Wang, T., & Liu, H. (2022) · Tissue and Cell · doi:10.1016/j.tice.2022.101926 · Cited by 3
Age-Related Macular Degeneration: Therapeutic Strategies Based on Stem Cells
Mathivanan, I., Enzmann, V., Thyagarajan, K., Sivasubramanian, A. T., Raju, K., & Thangaraj, A. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10917-5 · Cited by 4
“These outcomes suggest that retinal organoids could serve as a scalable and clinically relevant source of cells for transplantation-based therapies for conditions such as AMD and Stargardt’s macular dystrophy [ 106 ].”
Physiologic constraints of using exosomes in vivo as systemic delivery vehicles
Lee, D. S., Suh, M., Kang, S. Y., & Hwang, D. W. (2019) · Precision Nanomedicine · doi:10.33218/prnano2(3)070819.1 · Cited by 3
Yuan, Y., Kong, W., Liu, X., & Shi, G. (2023) · Current Medical Science · doi:10.1007/s11596-022-2684-3 · Cited by 2
Tran, H. T., Rodprasert, W., Padeta, I., Oontawee, S., Purbantoro, S. D., Thongsit, A., Siriarchavatana, P., Srisuwatanasagul, S., Egusa, H., Osathanon, T., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0318204 · Cited by 2
Farrer, L. A., & DeAngelis, M. M. (2017) · Stem Cell Investigation · doi:10.21037/sci.2017.10.07 · Cited by 3
“First, although several years have passed since retinal and RPE cells were first derived from human and mouse iPSCs (26,27) and successful submacular transplantation of RPE cells derived in this manner has been performed recently in two patients with neovascular AMD (28), use of transplanted of autologous iPSC-derived…”
BackgroundSomatic Cell Epigenetic Reprogramming: Molecular Mechanisms and Therapeutic Potential
Chen, Z., Pietrobon, A., Julian, L. M., & Stanford, W. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814879-2.00007-8 · Cited by 2
Cellular Reprogramming and Aging
Pereira, S. N., & de Jesus, B. B. (2020) · Learning materials in biosciences · doi:10.1007/978-3-030-43939-2_5 · Cited by 2
Kitahata, S., Ichikawa, H., Tanaka, Y., Inoue, T., & Kadonosono, K. (2020) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2020.100841 · Cited by 2
Intraoperative Optical Coherence Tomography
Gülkaş, S., & Çekıç, O. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81515 · Cited by 2
Zimmerlin, L., Park, T. S., Bhutto, I. A., Lutty, G. A., & Zambidis, E. T. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1908-7_10 · Cited by 2
Park, T. S., Zimmerlin, L., Evans-Moses, R., Thomas, J., Huo, J. S., Kanherkar, R., He, A., Ruzgar, N. M., Grebe, R. R., Bhutto, I. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/678599 · Cited by 2
Successful Correction of ALD Patient-derived iPSCs Using CRISPR/Cas9Preprint
Jung, E. S., Quan, Z., Chang, M., Hong, W., Kim, J. H., Kim, S. H., You, S., Kim, D., Jang, J., Lee, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.23.962118 · Cited by 2
Marmorstein, A. D., Scruggs, B. A., Knudsen, T., Hill, M., Kopp, F., Trncic, E., Korda, D., Atherton, E., Berger, A., Finnemann, S. C., et al. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1739620 · Cited by 2
“The first study using autologous iPSC-RPE observed a similar phenomenon (Mandai et al., 2017; Takagi et al., 2019; Souied et al., 2017), and Gupta et al. (2025) have recently noted that transplanted RPE salvage the CC as well as photoreceptors in a pig retinal degeneration model.”
Human Induced Pluripotent Stem (hiPS) Cells: Generation and Applications
Freund, C. M. A. H. (2020) · Learning materials in biosciences · doi:10.1007/978-3-030-43939-2_4 · Cited by 1
Shang, S., Chen, K., Cai, G., Bai, X., Chen, X., & Li, Q. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102316 · Cited by 1
Japanese Laws and the Current Status of Regenerative Medicine in the Tohoku Region
Kamano, Y., Terajima, N., Chiba, Y., Venkataiah, V. S., & Saito, M. (2023) · The Journal of Contemporary Dental Practice · doi:10.5005/jp-journals-10024-3487 · Cited by 2
Liu, Y., Li, K. V., Li, Z., Lu, Y., McNally, M. M., Esposito, E. P., Aziz, K., & Singh, M. S. (2024) · Journal of Visualized Experiments · doi:10.3791/65448 · Cited by 1
Digital transformation of myopic retinopathy: insights from the Asian perspective
Xu, J., He, H.-L., Chen, X.-Y., & Jin, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23637-2.00016-3 · Cited by 1
Bratt‐Leal, A. M., Zhang, A., Wang, Y., & Loring, J. F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00025-3 · Cited by 1
Terapia komórkowa w schorzeniach zwyrodnieniowych siatkówki – nadzieje i zagrożenia
Machalińska, A. (2020) · OphthaTherapy Therapies in Ophthalmology · doi:10.24292/01.ot.310320.04 · Cited by 1
“Pierwsze próby ich zastosowania w leczeniu wysiękowej postaci zwyrodnienia plamki żółtej związanego z wiekiem (AMD, age-related macular degeneration) podjęto w Japonii, jednak nie uzyskano spektakularnych efektów terapeutycznych [1].”
BackgroundAndré, A., & Zérah, M. (2019) · Operative Neurosurgery · doi:10.1093/ons/opz267 · Cited by 1
Zhang, K., Wang, Y., An, Q., Ji, H., Wu, D., Li, X., Dong, X., & Zhang, C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.22.586212 · Cited by 1
Survival of Transplanted Retinal Ganglion Cell in Human Donor Eyes under Elevated PressurePreprint
Hameed, S. S., Gupta, S. J., Ho, K., & Sharma, T. P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.22.650064 · Cited by 1
Promising Stem cells for Prosthodontics
Niibe, K., & Egusa, H. (2018) · Annals of Japan Prosthodontic Society · doi:10.2186/ajps.10.230
Stem Cell Therapy for Ophthalmic Vascular Disease
Regatieri, C. V., Vieira, A., & Nehemy, M. B. (2020) · Springer eBooks · doi:10.1007/978-3-030-56954-9_17
Advances in pluripotent stem cell-derived natural killer cells for cancer immunotherapy
Coffey, M., Yamamoto, K., & Kaufman, D. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824375-6.00008-4
Induced pluripotent stem cell–derived salivary glands
Tanaka, J., & Mishima, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823809-7.00004-9
Choi, K.-E., Kim, S., Yun, C., & Oh, J. (2021) · Retina · doi:10.1097/iae.0000000000003331
Compagnucci, C., Bertini, E., & Tartaglia, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85767-3.00008-6
Applications of Neural Organoids in Neurodevelopment and Regenerative Medicine
Gong, J., Kang, J., Li, M., Liu, X., Yang, J., & Xu, H. (2022) · Biomedical engineering · doi:10.5772/intechopen.104044
Induced Pluripotent Stem Cells: Progress toward Clinical Translation from Bench to Bedside
Fakoya, A. O. J., Omole, A. E., Satyadev, N., & Haider, K. H. (2022) · Springer eBooks · doi:10.1007/978-981-19-2655-6_40
Research Progress of Signal Pathways Related to Age-Related Macular Degeneration
邵, 欢. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.133587
Update on stem/progenitor cell-based clinical trials for eye disease
El-Hashash, A. H. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99987-8.00003-5
Follin, B., Caluori, G., Dobrolińska, M. M., Stachura, J., Muzzamil, H., Wojakowski, W., Qayyum, A. A., & Jadczyk, T. (2023) · Springer eBooks · doi:10.1007/978-981-99-0722-9_3
New Avenues of Delivery (Subretinal Gene Therapy, Port Delivery, Suprachoroidal)
Nair, A. A., Chaili, S., & Law, J. C. (2023) · Current practices in ophthalmology · doi:10.1007/978-981-99-1661-0_19
Wang, M., Idei, H., Wang, C., Liang, Y. T., Liu, Y., Matsuda, Y., Takahashi, K., Kamioka, H., & Naruse, K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.15.567696
Jiang, T., Huang, J., Xu, B., Ge, Z., Li, Y., Wei, L., Yu, L., & Li, J. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122816
Bao, Y. K., Engelhard, S., & Brant, R. (2024) · Springer eBooks · doi:10.1007/978-3-031-29358-0_21-1
Effect of the Sugar Present in the Culture Medium on the Preservation of Human RPE Cell Suspensions
Kitahata, S., Ichikawa, H., Tanaka, Y., Tanaka, S., Inoue, T., Maruyama-Inoue, M., & Kadonosono, K. (2025) · Translational Vision Science & Technology · doi:10.1167/tvst.14.2.1
Biomaterials in Retinal Regeneration
Hicks, E. A., Monteiro, A., Tran, N., Sheardown, L., & Sheardown, H. D. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781839169779-00256
Chemical reprogramming of fibroblasts into retinal pigment epithelium cells for vision restoration
Li, S., Liu, H., Pan, S., Zhu, Z., Zhang, S., Li, J., Yao, Y., Wang, X., Gao, N., Liu, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67104-w · Cited by 3
“7a and Supplementary Data 4).”
InfluentialLong‐term predictive outcomes of stem cell therapy for degenerative retinal diseases
He, H., Chen, X., Du, M., Li, Y., Wang, Y., & Jin, Z. (2025) · Eye & ENT Research · doi:10.1002/eer3.70028 · Cited by 1
Towards a better understanding of the role of ITM2B in the retina
Wohlschlegel, J. (2020) · theses.fr (ABES) · doi:10.70675/e9519354z82f8z43afz8844zf09061d0db21 · Cited by 1
Wang, Y., Cheng, S., Zhang, Y., & Yang, T. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1832772
“The convergence of these two approaches enables correction of disease-causing mutations at the cellular level followed by replacement of dysfunctional RPE, thereby addressing both genetic and cellular deficits (Schwartz et al., 2015; Mandai et al., 2017).”
InfluentialCell therapy for age-related macular degeneration
Shaikh, A., & Pera, M. F. (2026) · Mammalian Genome · doi:10.1007/s00335-026-10242-3
“…strategies to reduce the requirement for immunosuppression have been advanced, including autografts derived from patient iPSC (Takagi et al. 2019; Mandai et al. 2017), gene editing of HLA target molecules (Petrus-Reurer et al. 2020; Ishida et al. 2024), HLA matched donor cells (Sugita et al.…”
Krupalnik, V., Kawamata, S., Mountford, J. C., Muschler, G. F., Bando, H., Cui, W., Zhang, X., Ludwig, T. E., Munsie, L., Agabalyan, N. A., et al. (2026) · Cytotherapy · doi:10.1016/j.jcyt.2026.102969
3D epigenomic landscape of the human retinal pigment epithelium
Liu, X., Tang, D., Zhang, J., Li, T., Huang, J., Qu, J., Ruan, Y., Chai, H., & Chi, Z. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2526200123
“…- phase clinical trials in humans and extensive preclinical animal studies demonstrate that transplantation of iPSC - RPE con tributes to structural and functional improvements in the retina, exhibits a favorable safety profile, and achieves successful engraftment and survival of the cells (6, 7).”
Sakai, D., Hirami, Y., Takagi, S. T., Yamamoto, M., Totani, K., Yamanari, M., Fujihara, M., Sugita, S., Maeda, T., Takahashi, M., et al. (2026) · Ophthalmology Retina · doi:10.1016/j.oret.2026.09.005
Bao, Y. K., Engelhard, S., & Fernandes, R. A. B. [. (2026) · Springer eBooks · doi:10.1007/978-3-032-23052-2_21
Silverman, J. L., Haouchine, O. Y., Roy, D., & Monsen, E. R. (2026) · Current topics in behavioral neurosciences · doi:10.1007/7854_2026_617
Metadata
- Authors
- Souied, E. H., Pulido, J. S., & Staurenghi, G.
- Affiliations
- Université Paris-Est Créteil (FR)
- Mayo Clinic (US)
- University of Milan (IT)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-08-24
- Volume
- 377
- Issue
- 8
- Pages
- 792-793
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3149364280
- Cited by
- 171
- References
- 3
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 15 · 2023: 18 · 2022: 23 · 2021: 22 · 2020: 32 · 2019: 25 · 2018: 16 · 2017: 1
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- autologous stem cells, induced pluripotent stem cells, retinal cells, macular degeneration, cell therapy, retinal regeneration
- MeSH terms
- Humans, Macular Degeneration, Retina, Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.